Assessing Gingivitis and Plaque From a Marketed Toothpaste
← catalyst calendarSponsored by Procter and Gamble (industry) · PG — their whole pipeline →.
Phase
Phase 4
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · Triple · Treatment
Enrollment
120estimated
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-08-30 | actual | When the study began enrolling |
| Primary completion | 2025-12-07 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-12-07 | estimated | The whole study's end, after follow-up |
| First posted | 2025-09-05 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-09-23 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Gingivitis
Interventions
- Drug: Stannous Fluoride Dentifrice
- Drug: Test Stannous Fluoride Dentifrice
- Drug: Sodium monofluorophosphate dentifrice
Primary outcome
what the primary-completion date above is the date OFNumber of Bleeding Sites
measured 1 month and 3 months
Permalink · PG's whole pipeline · Catalyst calendar · Every registered study · What changed